L
Lucid Diagnostics D
D
LUCD
1.00000
USD
0.01
(1.09%)
Market Open
Volume
1,191
EPS
0
Div Yield
0
P/E
-1
Market Cap
49,344,945
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Lucid Diagnostics
Sector: Healthcare
Industry: Medical Devices
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.